First Trust NYSE Arca Biotechnology Index Fund
189 hedge funds and large institutions have $2.25B invested in First Trust NYSE Arca Biotechnology Index Fund in 2018 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 83 increasing their positions, 26 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
69% more call options, than puts
Call options by funds: $2.88M | Put options by funds: $1.71M
40.17% more ownership
Funds ownership: 54.06% → 94.23% (+40%)
20% more funds holding
Funds holding: 157 → 189 (+32)
Holders
189
Holding in Top 10
9
Calls
$2.88M
Puts
$1.71M
Top Buyers
| 1 | +$708M | |
| 2 | +$298M | |
| 3 | +$91.1M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$54.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$40.3M |
Top Sellers
| 1 | -$7.62M | |
| 2 | -$2.86M | |
| 3 | -$1.84M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$1.74M |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$1.53M |